G
Guggenheim Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
301 |
301
Dominion Energy
D
$49.7B
|
SP
Shahriar Pourreza
| $58.19 | $52 |
11%
downside
| Buy | 1 year ago |
|
302 |
302
Hims & Hers Health
HIMS
$10.9B
|
JW
Jack Wallace
| $48.41 | $17 |
65%
downside
| Buy | 1 year ago |
|
303 |
303
Celldex Therapeutics
CLDX
$1.52B
|
YS
Yatin Suneja
| $22.87 | $90 |
294%
upside
| Buy | 1 year ago |
|
304 |
304
CenterPoint Energy
CNP
$24.7B
|
SP
Shahriar Pourreza
| $37.78 | $32 |
15%
downside
| Buy | 1 year ago |
|
305 |
305
Axsome Therapeutics
AXSM
$6.25B
|
YS
Yatin Suneja
| $125.17 | $125 |
0%
downside
| Buy | 1 year ago |
|
306 |
306
Evergy
EVRG
$16.5B
|
SP
Shahriar Pourreza
| $71.60 | $52 |
27%
downside
| Neutral | 1 year ago |
|
307 |
307
NorthWestern Energy
NWE
$3.56B
|
SP
Shahriar Pourreza
| $57.95 | $47 |
19%
downside
| Neutral | 1 year ago |
|
308 |
308
Avista
AVA
$2.99B
|
SP
Shahriar Pourreza
| $36.87 | $34 |
8%
downside
| Neutral | 1 year ago |
|
309 |
309
Allete
ALE
$3.69B
|
SP
Shahriar Pourreza
| $63.65 | $58 |
9%
downside
| Neutral | 1 year ago |
|
310 |
310
NewAmsterdam Pharma
NAMS
$3.04B
|
DC
Debjit Chattopadhyay
| $27 | $30 |
11%
upside
| Buy | 1 year ago |
|
311 |
311
Castle Biosciences
CSTL
$683M
|
SN
Subbu Nambi
| $23.56 | $25 |
6%
upside
| Buy | 1 year ago |
|
312 |
312
Spyre Therapeutics
SYRE
$1.03B
| $17 | $44 |
159%
upside
| Buy | 1 year ago |
|
|
313 |
313
Arvinas
ARVN
$575M
|
MS
Michael Schmitz
| $7.83 | $40 |
411%
upside
| Buy | 1 year ago |
|
314 |
314
Roivant Sciences
ROIV
$8.82B
|
YS
Yatin Suneja
| $12.92 | $16 |
24%
upside
| Buy | 1 year ago |
|
315 |
315
MoonLake Immunotherapeutics
MLTX
$3.77B
|
YS
Yatin Suneja
| $59.44 | $77 |
30%
upside
| Buy | 1 year ago |
|
316 |
316
Xencor
XNCR
$610M
|
MS
Michael Schmidt
| $8.55 | $34 |
298%
upside
| Buy | 1 year ago |
|
317 |
317
IDEAYA Biosciences
IDYA
$2.38B
|
VZ
Vanck Zhu
| $27.16 | $44 |
62%
upside
| Buy | 1 year ago |
|
318 |
318
IQVIA
IQV
$31.9B
|
JW
Jack Wallace
| $187.68 | $220 |
17%
upside
| Buy | 1 year ago |
|
319 |
319
lululemon athletica
LULU
$19.9B
|
GF
Gregory Francfort
| $167.80 | $440 |
162%
upside
| Buy | 2 years ago |
|
320 |
320
Portland General Electric
POR
$4.69B
|
SP
Shahriar Pourreza
| $42.81 | $48 |
12%
upside
| Buy | 2 years ago |
|
321 |
321
Evolent Health
EVH
$1.11B
|
SD
Sandy Draper
| $9.61 | $47 |
389%
upside
| Buy | 2 years ago |
|
322 |
322
GoodRx Holdings
GDRX
$1.39B
|
SD
Sandy Draper
| $4 | $10 |
150%
upside
| Buy | 2 years ago |
|
323 |
323
ACV Auctions
ACVA
$2.03B
|
AF
Ali Faghri
| $11.81 | $21 |
78%
upside
| Buy | 2 years ago |
|
324 |
324
Merus
MRUS
$5.1B
|
CZ
Charles Zhu
| $67.47 | $48 |
29%
downside
| Buy | 2 years ago |
|
325 |
325
E.W. Scripps
SSP
$261M
|
CB
Curry Baker
| $2.95 | $10 |
239%
upside
| Neutral | 2 years ago |
|